Franklin Asian Equity Fund

Franklin Asian Equity Fund has delivered modest SIP XIRR across horizons, with 1Y at 11.52%, 3Y at 8.98%, and 5Y at 8.14%, all well below the category average SIP XIRR of 14.1%, 16.82%, and 16.95% respectively. On a lump-sum basis, the fund has outperformed the NIFTY 50 over 1Y (44.14% vs -2.9% CAGR) and 3Y (24.2% vs 7.75%), with positive alpha at every horizon up to 10Y, though the 15Y alpha of 1.13% shows the edge has narrowed over the long term. Calendar year returns are volatile, ranging from 36.22% in 2017 to -13.78% in 2022.

The fund shows low beta versus the NIFTY 50 (0.56-0.91 across horizons) and consistently low downside capture (50.38%-66.92%), indicating meaningful downside protection, while upside capture declines from 119% at 1Y to 56.15% at 15Y. The maximum drawdown of -0.40% was shallow but took 615 days to reach bottom and 1,074 days to recover, and the fund has experienced 6 drawdown events exceeding 10%. Calmar ratios of roughly 0.19-0.26 across horizons suggest moderate risk-adjusted efficiency.

The portfolio is diversified across 28 holdings with a low top-10 concentration, led by ICICI Bank at 3.41%, Torrent Pharmaceuticals at 2.45%, and Divi's Laboratories at 2.43%. Sector exposure is spread with Banks at 6.3%, Pharmaceuticals at 4.9%, and Realty at 3.9%, showing no single dominant theme despite the fund's sectoral/thematic classification. Holdings span banks, pharma, realty, consumer, metals, and capital goods, providing broad multi-sector exposure.

The fund trails its category significantly on SIP XIRR at every horizon, lagging the 12Y category average of 16.25% by over 7 percentage points with its own 8.40%. However, its lump-sum benchmark performance is stronger, with positive alpha versus NIFTY 50 across 1Y through 12Y horizons. The consistent downside capture below 67% suggests a defensive style that has preserved capital but limited upside participation relative to more aggressive peers.

This fund suits conservative investors seeking diversified equity exposure with lower volatility than the broad market, given its low beta and strong downside capture characteristics. A long time horizon of 7-10 years is appropriate, as the fund's lump-sum CAGR has converged toward benchmark levels over extended periods. Investors should have moderate risk tolerance and accept that SIP returns have persistently lagged the sectoral/thematic category average.

• Consistently low downside capture (50.38%-66.92%) versus NIFTY 50 across all horizons, providing strong capital protection in weak markets
• Positive alpha versus NIFTY 50 at every horizon from 1Y to 12Y, including 46.23% alpha over 1Y and 16.78% over 3Y
• Well-diversified 28-stock portfolio with low single-stock concentration (top holding at 3.41%) spread across multiple sectors

• SIP XIRR significantly lags the category average at all horizons, with the 5Y figure of 8.14% trailing the 16.95% category average by nearly 9 percentage points
• Long drawdown recovery profile, with the maximum drawdown taking 1,074 days to recover and 6 drawdown events exceeding 10% over the fund's history
• Upside capture has declined steadily from 119% at 1Y to 56.15% at 15Y, indicating the fund participates in only about half of market rallies over long periods